Guido Grandi

Trento, 38131, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

Investigation on antigen-specific T-cell responses induced by outer membrane vesicles from Escherichia coli Δ60 strain.

Investigation on antigen-specific T-cell responses induced by outer membrane vesicles from Escherichia coli Δ60 strain.

Journal: Frontiers in immunology
Published: May 23, 2025

Efficient and effective identification of cancer neoantigens from tumor only RNA-seq.

Efficient and effective identification of cancer neoantigens from tumor only RNA-seq.

Journal: NAR genomics and bioinformatics
Published: September 04, 2024

Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow.

Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow.

Journal: Journal of autoimmunity
Published: May 06, 2024

Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens.

Immunogenicity of Escherichia coli Outer Membrane Vesicles: Elucidation of Humoral Responses against OMV-Associated Antigens.

Journal: Membranes
Published: October 06, 2023

Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2.

Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2.

Journal: Vaccines
Published: September 08, 2023

Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.

Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.

Journal: Vaccines
Published: August 09, 2023

Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.

Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.

Journal: Research square
Published: June 09, 2023

Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles.

Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles.

Journal: Cancers
Published: April 26, 2023

Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells.

Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells.

Journal: Frontiers in oncology
Published: April 04, 2022

Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines.

Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines.

Journal: Vaccines
Published: October 08, 2021

Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis.

Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis.

Journal: Joint bone spine
Published: September 18, 2021

Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The Staphylococcus aureus Case.

Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The Staphylococcus aureus Case.

Journal: Frontiers in immunology
Published: August 02, 2021
Showing 1-12 of 64

Last Updated: 09/26/2026